The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulants market was valued at US$ 25950 million in 2023 and is anticipated to reach US$ 35930 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
Report Scope
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Johnson & Johnson.
- Genentech (Roche)
- Boehringer Ingelheim
- Lilly
- Daiichi Sankyo
- Otsuka
- AstraZeneca
- Pfizer
- Aspen
- The Medicines Company
Segment by Type
- Platelet Aggregation Inhibitors (PAI)
- Low-Molecular-Weight Heparin (LMWH)
- Direct Thrombin Inhibitor (DTI)
- Direct Factor Xa Inhibitors (DFXa)
- Vitamin K antagonists (VKA)
- Others
Segment by Application
- VTE
- ACS/MI
- AF
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulants Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Platelet Aggregation Inhibitors (PAI)
1.2.3 Low-Molecular-Weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Direct Factor Xa Inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Anticoagulants Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulants Market Perspective (2019-2030)
2.2 Anticoagulants Growth Trends by Region
2.2.1 Global Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anticoagulants Historic Market Size by Region (2019-2024)
2.2.3 Anticoagulants Forecasted Market Size by Region (2025-2030)
2.3 Anticoagulants Market Dynamics
2.3.1 Anticoagulants Industry Trends
2.3.2 Anticoagulants Market Drivers
2.3.3 Anticoagulants Market Challenges
2.3.4 Anticoagulants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulants Players by Revenue
3.1.1 Global Top Anticoagulants Players by Revenue (2019-2024)
3.1.2 Global Anticoagulants Revenue Market Share by Players (2019-2024)
3.2 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulants Revenue
3.4 Global Anticoagulants Market Concentration Ratio
3.4.1 Global Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulants Revenue in 2023
3.5 Anticoagulants Key Players Head office and Area Served
3.6 Key Players Anticoagulants Product Solution and Service
3.7 Date of Enter into Anticoagulants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulants Breakdown Data by Type
4.1 Global Anticoagulants Historic Market Size by Type (2019-2024)
4.2 Global Anticoagulants Forecasted Market Size by Type (2025-2030)
5 Anticoagulants Breakdown Data by Application
5.1 Global Anticoagulants Historic Market Size by Application (2019-2024)
5.2 Global Anticoagulants Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anticoagulants Market Size (2019-2030)
6.2 North America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anticoagulants Market Size by Country (2019-2024)
6.4 North America Anticoagulants Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticoagulants Market Size (2019-2030)
7.2 Europe Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anticoagulants Market Size by Country (2019-2024)
7.4 Europe Anticoagulants Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulants Market Size (2019-2030)
8.2 Asia-Pacific Anticoagulants Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anticoagulants Market Size by Region (2019-2024)
8.4 Asia-Pacific Anticoagulants Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anticoagulants Market Size (2019-2030)
9.2 Latin America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anticoagulants Market Size by Country (2019-2024)
9.4 Latin America Anticoagulants Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulants Market Size (2019-2030)
10.2 Middle East & Africa Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
10.4 Middle East & Africa Anticoagulants Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anticoagulants Introduction
11.1.4 Sanofi Revenue in Anticoagulants Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Anticoagulants Introduction
11.2.4 Bristol-Myers Squibb Revenue in Anticoagulants Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Anticoagulants Introduction
11.3.4 Bayer Revenue in Anticoagulants Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Johnson & Johnson.
11.4.1 Johnson & Johnson. Company Detail
11.4.2 Johnson & Johnson. Business Overview
11.4.3 Johnson & Johnson. Anticoagulants Introduction
11.4.4 Johnson & Johnson. Revenue in Anticoagulants Business (2019-2024)
11.4.5 Johnson & Johnson. Recent Development
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Company Detail
11.5.2 Genentech (Roche) Business Overview
11.5.3 Genentech (Roche) Anticoagulants Introduction
11.5.4 Genentech (Roche) Revenue in Anticoagulants Business (2019-2024)
11.5.5 Genentech (Roche) Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Anticoagulants Introduction
11.6.4 Boehringer Ingelheim Revenue in Anticoagulants Business (2019-2024)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Lilly
11.7.1 Lilly Company Detail
11.7.2 Lilly Business Overview
11.7.3 Lilly Anticoagulants Introduction
11.7.4 Lilly Revenue in Anticoagulants Business (2019-2024)
11.7.5 Lilly Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Detail
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Anticoagulants Introduction
11.8.4 Daiichi Sankyo Revenue in Anticoagulants Business (2019-2024)
11.8.5 Daiichi Sankyo Recent Development
11.9 Otsuka
11.9.1 Otsuka Company Detail
11.9.2 Otsuka Business Overview
11.9.3 Otsuka Anticoagulants Introduction
11.9.4 Otsuka Revenue in Anticoagulants Business (2019-2024)
11.9.5 Otsuka Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Anticoagulants Introduction
11.10.4 AstraZeneca Revenue in Anticoagulants Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Anticoagulants Introduction
11.11.4 Pfizer Revenue in Anticoagulants Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Aspen
11.12.1 Aspen Company Detail
11.12.2 Aspen Business Overview
11.12.3 Aspen Anticoagulants Introduction
11.12.4 Aspen Revenue in Anticoagulants Business (2019-2024)
11.12.5 Aspen Recent Development
11.13 The Medicines Company
11.13.1 The Medicines Company Company Detail
11.13.2 The Medicines Company Business Overview
11.13.3 The Medicines Company Anticoagulants Introduction
11.13.4 The Medicines Company Revenue in Anticoagulants Business (2019-2024)
11.13.5 The Medicines Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
